CompletedNCT03389750
A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.
Medication studyAges 21–55United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 21 years to 55 years.
- Listed locations
- Lexington and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: March 15, 2018
- Recruitment status
- Completed
- Enrollment listed in the registry
- 16
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 55 Years
- Official registry ID
- NCT03389750
- Official title
Show the full official title
A Randomized, Double-Blind, Placebo- and Active-Controlled, Crossover Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists in Physically Dependent Opioid Users With Moderate-to-Severe Opioid Use Disorder
Get this study by email
Recruitment & locations
CompletedLexington · New York
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Intravenous Challenge Drug.
Who was this study for?
Listed age limits: 21 years to 55 years.
